Senior management changes at Delcath
This article was originally published in Scrip
Delcath Sytems, a development stage speciality pharmaceutical and medical device company focused on oncology, has appointed Dr Graham Miao executive vice-president and CFO, and David McDonald, Delcath's previous CFO, executive vice-president of business development. Dr Miao joins Delcath from Dun & Bradstreet Corporation where he served as chief of staff of the global CFO organisation. He previously worked at Pagoda Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.